Basic Information
ID: ALA4341116
Type: Functional
Description: Cytotoxicity against patient derived inflammatory breast cancer cell spheroids assessed as increase in spheroid dissolution at 2.5 uM incubated for 24 hrs by bright field microscopic based Spheroids MARY-X assay
Organism: Homo sapiens
Cell type: Breast carcinoma cell
Activity Charts
Bioactivity
Activity Types for Assay ALA4341116
Activity
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 380.44 | 3.76 | 3.76 |
| 380.44 | 3.76 | 3.76 |
| 364.44 | 4.05 | 4.05 |
| 440.49 | 3.74 | 3.74 |
| 526.63 | 4.11 | 4.11 |
| 526.63 | 4.11 | 4.11 |
| 424.49 | 4.07 | 4.07 |
| 396.44 | 3.46 | 3.46 |
| 542.63 | 3.81 | 3.81 |
| 400.42 | 4.33 | 4.33 |
| 688.81 | 4.17 | 4.17 |
| 400.42 | 4.33 | 4.33 |
| 394.42 | 2.34 | 2.34 |